Childhood C-Reactive Protein in Predicting CRP and Carotid Intima-Media Thickness in Adulthood: The Cardiovascular Risk in Young Finns Study
暂无分享,去创建一个
[1] M. Laakso,et al. High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study. , 2006, Diabetes care.
[2] A. Maseri,et al. Not So Mural Thrombus , 2006 .
[3] J. Viikari,et al. Increased Aortic Intima-Media Thickness in 11-Year-Old Healthy Children With Persistent Chlamydia pneumoniae Seropositivity , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[4] A. Khera,et al. Relationship Between C-Reactive Protein and Subclinical Atherosclerosis: The Dallas Heart Study , 2005, Circulation.
[5] J. Viikari,et al. Distribution and determinants of serum high‐sensitive C‐reactive protein in a population of young adults. The Cardiovascular Risk in Young Finns Study , 2005, Journal of internal medicine.
[6] E. Yeh,et al. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. , 2005, Journal of the American College of Cardiology.
[7] Mika Kähönen,et al. Risk Factors Identified in Childhood and Decreased Carotid Artery Elasticity in Adulthood: The Cardiovascular Risk in Young Finns Study , 2005, Circulation.
[8] J. Giddings,et al. C-Reactive Protein–Induced In Vitro Endothelial Cell Activation Is an Artefact Caused by Azide and Lipopolysaccharide , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[9] J. Strong,et al. Elevated Serum C-Reactive Protein Levels and Advanced Atherosclerosis in Youth , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[10] A. Mokdad,et al. The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. , 2005, Diabetes care.
[11] J. Jansson,et al. Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at -70 degrees C for 8-11 years. , 2005, Thrombosis research.
[12] W. Roberts. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice Laboratory Tests Available to Assess Inflammation— Performance and Standardization A Background Paper , 2004, Circulation.
[13] George A Mensah,et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview. , 2004, Circulation.
[14] E. Levy,et al. C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. , 2004, Clinical chemistry.
[15] Vilmundur Gudnason,et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.
[16] J. Viikari,et al. The 21‐year follow‐up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east–west difference , 2004, Journal of internal medicine.
[17] O. Raitakari,et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood , 2004 .
[18] H. Mcgill,et al. Starting earlier to prevent heart disease. , 2003, JAMA.
[19] T. Laitinen,et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. , 2003, JAMA.
[20] E. Ford. C-Reactive Protein Concentration and Cardiovascular Disease Risk Factors in Children: Findings From the National Health and Nutrition Examination Survey 1999–2000 , 2003, Circulation.
[21] D. Mannino,et al. C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000. , 2003, Clinical chemistry.
[22] Sidney C. Smith,et al. MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .
[23] D. Atkins,et al. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. , 2003, Circulation.
[24] P. Ridker,et al. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. , 2003, Journal of the American College of Cardiology.
[25] Gary L Myers,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.
[26] K. Hirata,et al. Interaction of Oxidative Stress and Inflammatory Response in Coronary Plaque Instability: Important Role of C-Reactive Protein , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[27] Jin-Biou Chang,et al. Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children. , 2003, Journal of clinical epidemiology.
[28] T. Lehtimäki,et al. Elevated Serum C-Reactive Protein Levels and Early Arterial Changes in Healthy Children , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[29] J. Dawson,et al. Carotid Intimal-Medial Thickness Is Related to Cardiovascular Risk Factors Measured From Childhood Through Middle Age: The Muscatine Study , 2001, Circulation.
[30] V. Hombach,et al. C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages: Implications for Atherosclerosis , 2001, Circulation.
[31] James T. Willerson,et al. Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells , 2000, Circulation.
[32] W. Koenig,et al. C-Reactive Protein in the Arterial Intima: Role of C-Reactive Protein Receptor–Dependent Monocyte Recruitment in Atherogenesis , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[33] J. Strong,et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[34] K. Kario,et al. Five-year intra-individual variability in C-reactive protein levels in a Japanese population-based study: the Jichi Medical School Cohort Study at Yamato, 1993-1998. , 2000, Japanese circulation journal.
[35] D. Strachan,et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. , 2000, Atherosclerosis.
[36] N Rifai,et al. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. , 1999, Clinical chemistry.
[37] M. Pfeffer,et al. Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein , 1999 .
[38] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[39] M. Pfeffer,et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. , 1999, Circulation.
[40] H. Mcgill,et al. Determinants of atherosclerosis in the young , 1998 .
[41] R. Tracy,et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. , 1998, The New England journal of medicine.
[42] M. Pepys,et al. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. , 1998, Clinical chemistry.
[43] D. Strachan,et al. C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.
[44] J. Viikari,et al. Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: a 12-year follow-up. The Cardiovascular Risk in Young Finns study. , 1994, American journal of epidemiology.
[45] P. Allhoff,et al. Bogalusa Heart Study , 2020, Encyclopedia of Behavioral Medicine.
[46] J V Castell,et al. Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.
[47] Reynolds Gd,et al. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. , 1987 .
[48] R. Vance,et al. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. , 1987, Archives of pathology & laboratory medicine.
[49] J. Viikari,et al. Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross‐sectional study of 1980, and an account of the children's and families' state of health , 1985, Acta paediatrica Scandinavica. Supplement.
[50] R. Lauer,et al. Tracking of Blood Lipids and Blood Pressures in School Age Children: The Muscatine Study , 1978, Circulation.